Adama Regional Public Health Lab
A study to confirm persistence/recrudescence of trachoma and understand factors facilitating on-going transmission in six districts across Oromia and SNNP regions of Ethiopia
Is there concordance in the TF, infection and serology data (at EU level) in confirming persistence and/or recrudescence of trachoma and the need for on-going interventions?
(1) How does TF, anti-Ct antibody and infection data correlate at cluster level and what implications does this have for targeting programmatic interventions?
(2) Are there treatment coverage, geographic, demographic, and WASH factors that are correlated with higher pgp3 antibody, Ct infection and/or TF prevalence that could inform more effective program interventions?
(3) Are there sociocultural and behavioural factors that are associated with higher TF prevalence that could inform more effective program interventions?
Antibody Responses to Chlamydia trachomatis Antigens in Trachoma-Endemic Zones of Ethiopia
To analyze the relationships between the currently used indicator for impact assessments - prevalence of the clincial sign TF - and the prevalence of infection and antibody among 1-9 year old children in hyperendemic districts prior to mass drug administration
Antibody Responses to Chlamydia trachomatis Antigens in Trachoma-Endemic Zones of Ethiopia
To analyze the relationships between the currently used indicator for impact assessments - prevalence of the clincial sign TF - and the prevalence of infection and antibody among 1-9 year old children in hyperendemic districts prior to mass drug administration